Stay updated about latest news and where to meet us!
02 September 2019. Today, Samplix is happy to announce the commercial launch of our Xdrop™ instrument for the targeted enrichment of long genomic regions from as little as 1 ng of DNA.
Scientists in the genomics field can now routinely capture up to 100 kb long genomic regions, based upon very limited target sequence information (100-200 bp of sequence). Using Xdrop™ technology together with long- or short-read sequencers makes it possible to sequence into regions that were previously inaccessible.
The types of genomic regions that are now unlocked by the Xdrop™ technology include:
Today, Samplix announced the commercial launch of its Xdrop™ sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity.
To read more, please see the full press release here:
Samplix is pleased to announce we will be demonstrating our recently launched Xdrop™ system at the EMBL Heidelberg Cancer Genomics 2019 conference in Heidelberg.
To see more and register for the event, please visit the conference website:
Samplix is pleased to announce we will be attending the Genomic Medicine 2019 Nordic conference 13 - 14 November at Kennedy Center at Rigshospitalet in Copenhagen.
Samplix is pleased to announce we will be attending the Genomic Medicine 2019 Cambridge conference 20 - 21 November at Murray Edwards College in Cambridge, UK
January 2019. Samplix is pleased to announce that the company has been selected by the European Commission among the winners of the prestigious Horizon 2020 – SME Instrument program, obtaining €1.9 million to mature its proprietary Xdrop™ technology. The selection process was highly competitive with more than 1.800 applicants and a success rate of only about 3%.
Samplix’ proprietary Xdrop™ technology comprises novel microfluidics, chemistry and bioinformatics in a simple work process that allows scientists and clinicians to partition millions of single molecules in droplets, thereby enabling both targeted enrichment and high-quality amplification of single molecules for sequencing analysis.
The Xdrop™ technology is currently in beta test at leading research institutions world-wide.
“We are excited to receive recognition and support by the European Commission for completion of our product development towards commercial launch of the Xdrop™ solution later this year” said CEO Lars Kongsbak.
To read more about Horizon 2020 SME awards, please viisit European Commission website:
ContactMileparken 282730 HerlevDenmark
email@example.comPhone: (+45) 82 30 45 00
CVR 32 30 93 21
Connect with us
2019 Samplix ApS. All rights reserved. For Research Use Only. Not for use in diagnostic procedures.